Canada Gazette, Part I, Volume 148, Number 31: GOVERNMENT NOTICES

August 2, 2014

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Waiver of information requirements for living organisms (subsection 106(9) of the Canadian Environmental Protection Act, 1999)

Whereas any person who proposes to import or manufacture a living organism that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(1) of the Canadian Environmental Protection Act, 1999;

Whereas any person who proposes to use, manufacture or import for a significant new activity a living organism that is on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(3) of the Canadian Environmental Protection Act, 1999;

Whereas any person who proposes to use for a significant new activity a living organism that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(4) of the Canadian Environmental Protection Act, 1999;

Whereas a person may, pursuant to subsection 106(8) of the Canadian Environmental Protection Act, 1999, request any of the requirements to provide information under subsection 106(1), (3) or (4) of the Canadian Environmental Protection Act, 1999 to be waived; and

Whereas a waiver may be granted by the Minister of the Environment under subsection 106(8) of the Canadian Environmental Protection Act, 1999 if

• (a) in the opinion of the Ministers, the information is not needed in order to determine whether the living organism is toxic or capable of becoming toxic;
• (b) the living organism is to be used for a prescribed purpose or manufactured at a location where, in the opinion of the Ministers, the person requesting the waiver is able to contain the living organism so as to satisfactorily protect the environment and human health; or
• (c) it is not, in the opinion of the Ministers, practicable or feasible to obtain the test data necessary to generate the information;

Therefore, notice is hereby given, pursuant to subsection 106(9) of the Canadian Environmental Protection Act, 1999, that the Minister of the Environment waived the requirement to provide information in accordance with the following annex pursuant to subsection 106(8) of that Act.

KAREN L. DODDS
Assistant Deputy Minister
Science and Technology Branch

On behalf of the Minister of the Environment

ANNEX

Waiver of Information Requirements (Subsection 106(9) of the Canadian Environmental Protection Act, 1999)

Person to whom a waiver is granted	Information in relation to which a waiver is granted (see note 1)
Agriculture and Agri-Food Canada	Data from tests of antibiotic susceptibility (2)

Note 1
The number of times the information requirement was waived for the company is indicated in brackets.

EXPLANATORY NOTE

The decision to grant a waiver is made on a case-by-case basis by Environment Canada in consultation with Health Canada. On average, approximately 100 waivers are granted yearly for chemicals, polymers and organisms for an average of 450 notifications received.

For more information, please see the waivers Web page on the New Substances Web site at www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=7F19FF4B-1.

[31-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Waiver of information requirements for substances (subsection 81(9) of the Canadian Environmental Protection Act, 1999)

Whereas any person who proposes to import or manufacture a substance that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(1) of the Canadian Environmental Protection Act, 1999;

Whereas any person who proposes to use, manufacture or import for a significant new activity a substance that is on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(3) of the Canadian Environmental Protection Act, 1999;

Whereas any person who proposes to use for a significant new activity a substance that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(4) of the Canadian Environmental Protection Act, 1999;

Whereas a person may, pursuant to subsection 81(8) of the Canadian Environmental Protection Act, 1999, request any of the requirements to provide information under subsections 81(1), (3) or (4) of the Canadian Environmental Protection Act, 1999 to be waived; and

Whereas a waiver may be granted by the Minister of the Environment under subsection 81(8) of the Canadian Environmental Protection Act, 1999 if

• (a) in the opinion of the Ministers, the information is not needed in order to determine whether the substance is toxic or capable of becoming toxic;
• (b) the substance is to be used for a prescribed purpose or manufactured at a location where, in the opinion of the Ministers, the person requesting the waiver is able to contain the substance so as to satisfactorily protect the environment and human health; or
• (c) it is not, in the opinion of the Ministers, practicable or feasible to obtain the test data necessary to generate the information;

Therefore, notice is hereby given, pursuant to subsection 81(9) of the Canadian Environmental Protection Act, 1999, that the Minister of the Environment waived the requirement to provide information in accordance with the following annex pursuant to subsection 81(8) of that Act.

KAREN L. DODDS
Assistant Deputy Minister
Science and Technology Branch

On behalf of the Minister of the Environment

ANNEX

Waiver of Information Requirements (Subsection 81(9) of the Canadian Environmental Protection Act, 1999)

Person to whom a waiver is granted	Information in relation to which a waiver is granted
Bayer Material Science LLC	Data from a water solubility test Data from an octanol-water partition coefficient test
Danisco Canada Inc.	Data from a melting point test Data from a boiling point test Data from a density test Data from a vapour pressure test Data from an octanol-water partition coefficient test
Equistar Chemicals LP	Data from an octanol-water partition coefficient test
Evonik Canada Inc.	Data from an octanol-water partition coefficient test
Huntsman International (Canada) Corporation	Data from an octanol-water partition coefficient test
Lubrizol Canada Ltd.	Data from an octanol-water partition coefficient test Data from a hydrolysis as a function of pH test
Patheon Inc.	Data from a vapour pressure test Data from an acute mammalian toxicity test Data from a skin irritation test Data from a skin sensitization test

EXPLANATORY NOTE

The decision to grant a waiver is made on a case-by-case basis by Environment Canada in consultation with Health Canada. On average, approximately 100 waivers are granted yearly for chemicals, polymers and organisms for an average of 450 notifications received.

For more information, please see the waivers Web page on the New Substances Web site at www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=7F19FF4B-1.

[31-1-o]

DEPARTMENT OF THE ENVIRONMENT

FISHERIES ACT

Notice respecting the Agreement between the Government of New Brunswick and the Government of Canada regarding the administration of the Wastewater Systems Effluent Regulations in New Brunswick

Notice is hereby given that the Minister of the Environment has concluded with New Brunswick the annexed agreement entitled “Administrative Agreement between the Government of New Brunswick and the Government of Canada Regarding the Administration of the Wastewater Systems Effluent Regulations in New Brunswick”. This agreement is published further to subsection 4.1(4) of the Fisheries Act.

For further information, contact James Arnott, Wastewater Program, Department of the Environment, 351 Saint-Joseph Boulevard, Gatineau, Quebec K1A 0H3, ww-eu@ec.gc.ca (email).

Ottawa, June 30, 2014

LEONA AGLUKKAQ
Minister of the Environment

ADMINISTRATIVE AGREEMENT BETWEEN THE GOVERNMENT OF NEW BRUNSWICK AND THE GOVERNMENT OF CANADA REGARDING THE ADMINISTRATION OF THE WASTEWATER SYSTEMS EFFLUENT REGULATIONS IN NEW BRUNSWICK

This Administrative Agreement is made between:

THE GOVERNMENT OF CANADA as represented by the Minister of the Environment (herein referred to as “Canada”), of the first part

AND

THE GOVERNMENT OF NEW BRUNSWICK as represented by the Minister of Environment and Local Government (herein referred to as “New Brunswick”), of the second part

WHEREAS Canada and New Brunswick are signatories to the Canada-wide Strategy for the Management of Municipal Wastewater Effluent that establishes national performance standards for effluent quality from wastewater systems that discharge wastewater effluent to surface water and establishes a one-window approach to governance so owners and operators of wastewater systems deal with a single regulatory body;

AND WHEREAS Canada published the Wastewater Systems Effluent Regulations as one of the federal government's commitments to implement the Canada-wide Strategy for the Management of Municipal Wastewater Effluent;

AND WHEREAS New Brunswick promulgated the Water Quality Regulation - Clean Environment Act which aims to protect provincial waters from pollution through, among other measures, the issuance of approvals to construct, modify or operate wastewater works;

AND WHEREAS New Brunswick has in place its Compliance and Enforcement Policy, and Canada has in place its Compliance and Enforcement Policy for the Habitat Protection and Pollution Prevention Provisions of the Fisheries Act, November 2001, and both policy documents are publicly available;

AND WHEREAS Canada and New Brunswick recognize that there is a benefit to adopting a cooperative and harmonized approach to reduce administrative duplication resulting from comparable legislative and regulatory provisions, and that there is a need to specify the procedures of this approach in an agreement;

AND WHEREAS Canada and New Brunswick agree that New Brunswick, due to its existing relationship with owners and operators of municipally, privately, and provincially owned wastewater systems, is well positioned to act as the point of contact for the administration of the Wastewater Systems Effluent Regulations;

AND WHEREAS section 4.1 of the Fisheries Act and the Order Designating the Minister of the Environment as the Minister Responsible for the Administration and Enforcement of Subsections 36(3) to (6) of the Fisheries Act enable the Minister of the Environment to enter into agreements with a province to further the purposes of the Act, including facilitating joint action in areas of common interest, reducing overlap and harmonizing respective programs;

AND WHEREAS section 15 of the Clean Environment Act enables New Brunswick to enter into agreements with the Government of Canada relating to any matter pertaining to the environment;

AND WHEREAS the Government of New Brunswick, pursuant to order 2009-29 dated January 29, 2009, authorized the Minister of Environment and Local Government to enter into the Canada-wide Strategy for the Management of Municipal Wastewater Effluent and by extension this Administrative Agreement identified therein;

NOW THEREFORE Canada and New Brunswick (herein referred to as the “Parties”, collectively, and “Party” individually) agree as follows:

1. DEFINITIONS AND INTERPRETATION

1.1 “Agreement” means this Administrative Agreement and includes annexes A and B and any amendments made to the Agreement.

1.2 “Approval to Operate” means an approval or certificate of approval, including any appendices, amendments, or renewals, issued to the owner or operator of a Wastewater Works by the New Brunswick Minister of Environment and Local Government pursuant to section 8 of the New Brunswick Water Quality Regulation 82-126 under the Clean Environment Act, which sets out the terms and conditions by which a Wastewater Works, as defined in section 1.14 below, may be operated, and which has not expired or been suspended or cancelled.

1.3 “Authorization Officer” has the same meaning as that set out in section 1 of the Wastewater Systems Effluent Regulations.

1.4 “Clean Environment Act” means the Clean Environment Act R.S.N.B. 1973, c. C-6, as amended.

1.5 “Compliance Promotion” means any actions or measures, including site visits, taken by Canada or New Brunswick that promotes conformity with the Wastewater Systems Effluent Regulations.

1.6 “Enforcement Activities” means the activities and measures undertaken by specifically designated personnel as described in the Compliance and Enforcement Policy for the Habitat Protection and Pollution Prevention Provisions of the Fisheries Act, 2001, as amended from time to time, and in the New Brunswick Environment Compliance and Enforcement Policy, as amended from time to time.

1.7 “Environment Canada” means the Department of the Environment of the Government of Canada.

1.8 “ERRIS” means the Effluent Regulatory Reporting Information System, a web-based national reporting system used to collect and store the information reported under the Wastewater Systems Effluent Regulations.

1.9 “Fisheries Act” means the Fisheries Act, R.S.C., 1985, c. F-14, as amended.

1.10 “Management Committee” means the committee that the Parties agree to establish as described in section 4.6 and in Annex B of this Agreement.

1.11 “Manager” means the Manager of the Water and Wastewater Management Section of the New Brunswick Department of Environment and Local Government;

1.12 “Wastewater System” has the same meaning as set out in section 1 of the Wastewater Systems Effluent Regulations.

1.13 “Wastewater Systems Effluent Regulations” means the regulations registered as SOR/2012-139 made under the Fisheries Act and published in the Canada Gazette, Part II, on July 18, 2012, as amended from time to time. They are referred to as the “WSER” throughout this Agreement.

1.14 “Wastewater Works” has the same meaning as set out in section 1 of the Clean Environment Act.

1.15 “Water Quality Regulation” means the Water Quality Regulation - Clean Environment Act, a New Brunswick Regulation (82-126) made under the Clean Environment Act.

1.16 “WSER Regulated Community” means the owners and operators of Wastewater Systems in New Brunswick which are municipally, privately or provincially owned or operated and subject to the Wastewater Systems Effluent Regulations.

1.17 For the purposes of interpretation, the words in the singular include the plural and vice-versa and words in one gender include all genders.

2. PURPOSE AND OBJECTIVES OF THE AGREEMENT

2.1 Purpose

The purpose of this Agreement is to facilitate cooperation between the Parties with respect to the administration and enforcement of the Wastewater Systems Effluent Regulations and to reduce regulatory duplication resulting from comparable federal and provincial legislation with respect to wastewater in New Brunswick.

2.2 Objectives

The objectives of this Agreement are the following:

2.2.1 Identify the holder of the position designated as the Authorization Officer in New Brunswick for Column 3 of Schedule 1 of the WSER and his/her duties as related to the administration of these regulations.

2.2.2 Describe roles and responsibilities for the Parties in order to facilitate cooperation in the administration of the WSER, including recognizing that New Brunswick will be the point of contact for the administration of the WSER for the WSER Regulated Community.

2.2.3 Describe how the Parties will endeavour to cooperate with respect to Enforcement Activities taking place under their respective responsibilities, to help increase the effectiveness and efficiency of each Party's enforcement efforts, while recognizing that Canada is at all times responsible for the enforcement of the WSER, and that New Brunswick is at all times responsible for the enforcement of the Water Quality Regulation.

2.2.4 Describe the procedures for the Parties' collaboration relative to the ERRIS for the reporting of information in accordance with the requirements in the WSER and in the Approvals to Operate.

2.2.5 Establish a Management Committee to oversee the implementation of this Agreement.

3. PRINCIPLES

3.1 The Parties' decisions will be based on science and risk management approaches to achieve positive environmental and health results.

3.2 The Parties will act to address environmental matters in ways which respect their jurisdiction and responsibilities. Nothing in this Agreement alters the legislative or other authority of the governments or the rights of any of them with respect to the exercise of their legislative or other authorities under the Constitution of Canada.

3.3 The Parties agree on the importance of timeliness and minimal duplication throughout the implementation of this Agreement.

3.4 The Parties recognize the importance of regular and open communication to ensure effective information sharing and cooperation, and prevent overlapping activities and disputes between the Parties to this Agreement.

4. ACTIVITIES COVERED BY THIS AGREEMENT

The Parties agree to collaborate in carrying out the following activities:

4.1 Authorization Officer for the WSER

4.1.1 The Manager is designated as the Authorization Officer for the purpose of the WSER for the province of New Brunswick as set out in Column 3 of Schedule 1 of the WSER.

4.1.2 Canada will provide, if requested by New Brunswick, training on the WSER to the Manager and his/her officials, either at a face-to-face meeting or through other means, as deemed feasible by Canada.

4.2 Reporting

4.2.1 For the purposes of subsections 18(4), 19(4), and 48(1) of the WSER, the ERRIS is the electronic reporting system specified by Canada to be used by owners and operators of Wastewater Systems for submitting or reporting information set out in sections 18, 19, 20, 25, 35, 40 and 44, and subsection 29(2) of the WSER.

4.2.2 The Parties agree that Canada will provide access to the ERRIS to the owners and operators of municipally, privately, provincially or federally owned or operated Wastewater Systems in New Brunswick operating under Approvals to Operate, for the purpose of reporting the information required under those Approvals to Operate, and will allow New Brunswick to access this information to assess compliance with those Approvals to Operate.

4.2.3 Where the WSER Regulated Community submits, in paper format, information for the purposes of reporting under sections 18, 19, 20, 25, 35, 40 or 44, and subsection 29(2) of the WSER, the Manager will enter said information into the ERRIS.

4.2.4 New Brunswick will keep all WSER-related information submitted or reported in paper format by the WSER Regulated Community for the term of this Agreement. No later than three months following termination or expiry of this Agreement, New Brunswick will provide all of the paper documents to the manager of the wastewater program at Environment Canada.

4.2.5 Canada will provide the Manager with sufficient privileged access to the ERRIS to carry out his/her responsibilities in respect of the WSER. In so doing, Canada grants the Manager the right to use, download, reproduce and distribute WSER-related information in the ERRIS. Canada explicitly does not grant the right to modify or remove WSER-related information from the ERRIS.

4.2.6 Canada will provide the Manager with sufficient privileged access to the ERRIS to carry out his/her responsibilities in respect of the reporting provisions as per the Approvals to Operate. In so doing, Canada grants to the Manager the right to use, download, remove, reproduce or distribute information related to the Approvals to Operate in the ERRIS.

4.2.7 Canada will provide guidance materials and training on the ERRIS to the Manager and his/her officials, as required by New Brunswick.

4.2.8 The Parties' roles and responsibilities concerning the ERRIS are detailed in Annex A.

4.3 Program Administration for the WSER

4.3.1 New Brunswick will be the point of contact for the WSER for the WSER Regulated Community.

4.3.2 New Brunswick will review the information submitted by the WSER Regulated Community through the ERRIS.

4.3.3 New Brunswick, while providing information and guidance and undertaking measures to encourage compliance with the requirements of the Approvals to Operate issued under the Water Quality Regulation, will also provide information and guidance to the WSER Regulated Community as appropriate to promote awareness of WSER requirements.

4.3.4 New Brunswick, when identifying Wastewater System owners and operators suspected of non-compliance with the Water Quality Regulation, will also identify members of the WSER Regulated Community suspected of non-compliance with the WSER. New Brunswick will inform the manager of the wastewater program, Environment Canada, of the status of the latter, and of the measures undertaken as per section 4.3.3 of this Agreement to promote awareness of WSER requirements among those owners and operators.

4.3.5 New Brunswick will inform the manager of the wastewater program, Environment Canada, when initiating enforcement measures regarding a member of the WSER Regulated Community suspected of non-compliance under the Water Quality Regulation.

4.3.6 New Brunswick will document for each interaction (communications, site visits, etc.) with the WSER Regulated Community, the date, nature of interactions, name and titles of persons contacted, and measures undertaken to promote awareness of WSER requirements, and provide this information to the manager of the wastewater program, Environment Canada, as requested and within the time frame requested.

4.3.7 New Brunswick will provide an annual summary to the Management Committee regarding activities under sections 4.3.5 and 4.3.6 of this Agreement on or before April 30 of each year, for the previous calendar year.

4.4 Cooperation on Compliance Promotion

4.4.1 The Parties will collaborate in delivering regional presentations to the WSER Regulated Community and the owners and operators of municipally, privately, provincially or federally owned or operated Wastewater Systems in New Brunswick operating under Approvals to Operate on the WSER and the Water Quality Regulation including their respective authorizations during the term of this Agreement.

4.4.2 The Parties will collaborate on assessing how best to use the wastewater and municipal associations to provide information to the WSER Regulated Community during the term of this Agreement.

4.4.3 Canada is responsible for the development of the Compliance Promotion materials for the WSER.

4.5 Cooperation on Enforcement

4.5.1 The Parties agree to cooperate with respect to Enforcement Activities taking place under their respective responsibilities. This cooperation may include, but is not limited to, planning and coordination of Enforcement Activities, sharing information, undertaking joint inspections, and other activities as deemed appropriate. The means of cooperation will be established by the Management Committee as described in section 2.2 of Annex B to this Agreement.

4.5.2 Canada is the point of contact for the enforcement of the WSER and remains responsible at all times for the enforcement of the WSER and the pollution prevention provisions of the Fisheries Act.

4.5.3 New Brunswick is the point of contact for the enforcement of the Water Quality Regulation and remains responsible at all times for its enforcement.

4.6 Management Committee for this Agreement

4.6.1 The Parties will establish a Management Committee to oversee the implementation of this Agreement.

4.6.2 The roles and responsibilities of the Management Committee are described in the terms of reference appended to this Agreement as Annex B.

5. ACCOUNTABILITY

5.1 Each Party remains ultimately accountable and legally responsible for the administration and enforcement of their own regulatory and legislative requirements with respect to wastewater effluent.

6. ACCESS TO INFORMATION AND PRIVACY

6.1 The Parties expressly acknowledge that their respective access to information and protection of privacy legislation applies to information gathered by or exchanged between parties for the purpose of complying with this Agreement, and agree to work together to honour and respect each other's legal obligations under that legislation.

6.2 The Parties agree to notify each other through the Management Committee of any application for access to information received relating to this Agreement.

7. FINANCIAL PROVISIONS

7.1 Canada will provide financial compensation to New Brunswick in the total amount of $61,042, for the term of this Agreement, for the activities set out in this Agreement undertaken by New Brunswick that are above and beyond the New Brunswick commitment to implement the Canada-wide Strategy for the Management of Municipal Wastewater Effluent.

7.2 Payment of the total amount will be made as a one-time transfer, following the signature of the Agreement.

7.3 In the event that this Agreement is terminated by either Party prior to the end of the term of this Agreement, New Brunswick will reimburse Canada said amount in section 7.1 of this Agreement on a prorated basis in respect of the time remaining in the prescribed term of this Agreement as set out in section 9.3 of this Agreement.

8. AMENDMENT AND REVIEW OF THIS AGREEMENT

8.1 This Agreement may be amended from time to time by mutual written consent of the Ministers.

8.2 Canada will conduct a review of this Agreement six months before its expiry. The review will, at minimum, determine whether the objectives, roles and responsibilities, and activities undertaken have been met, and identify any corrective action that may be required. The review report will be made available to the Management Committee. Canada will retain the intellectual property rights and interests in the review report. In the event that New Brunswick wishes to contribute to the review or to conduct a joint review of the Agreement with Canada, the Parties will collaborate to establish how the review will be carried out, addressing at minimum the requirements described above, and managed, and adequately deal with the question of intellectual property rights and interests in the review report.

9. EXECUTION, DURATION AND TERMINATION OF THE AGREEMENT

9.1 This Agreement may be signed in several counterparts and each counterpart shall constitute an original document; these counterparts taken together shall constitute one and the same Agreement. The Parties agree that executed counterparts may be transmitted by facsimile machine and that such counterparts shall be treated as originally executed instruments. Each Party undertakes to provide the other Party with an original copy of the Agreement bearing their respective actual original signatures within a reasonable period of time following execution of this Agreement.

9.2 This Agreement becomes effective as of the date of the last signature affixed to this Agreement.

9.3 This Agreement terminates three years after the date on which it comes into effect.

9.4 This Agreement may be terminated earlier by either Party giving the other Party at least six months written notice of termination through the co-chairperson of the Management Committee of the other Party.

10. SURVIVAL FOLLOWING TERMINATION OF THIS AGREEMENT

10.1 New Brunswick may request continued access to the ERRIS for a period beyond the term of this Agreement for the Manager, sufficient to carry out his/her responsibilities in respect of the reporting provisions as per the Approvals to Operate, in accordance with section 4.2.6 of this Agreement, and for the owners and operators of municipally, privately, provincially, and federally owned or operated Wastewater Systems operating under Approvals to Operate, for the purposes of reporting the information required under the Approvals to Operate in accordance with section 4.2.2 of this Agreement. Such a request must be submitted to Canada in writing to the co-chairperson of the Management Committee for Canada no later than three months before the termination of this Agreement.

10.2 Where New Brunswick submits a written request for continued access to the ERRIS as per section 10.1 of this Agreement, sections 4.2.2 and 4.2.6 of this Agreement, and sections 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 2.11, 2.12, 2.13, 3, and 4.3 of Annex A to this Agreement will survive the term of this Agreement for a period of two years or a period otherwise agreed upon in writing by the Parties.

11. DISPUTE RESOLUTION

11.1 The Parties agree that any dispute between them with respect to the interpretation, implementation and administration of this Agreement is to be resolved by the co-chairpersons of the Management Committee within 20 business days of the dispute being brought to the attention of the co-chairpersons.

11.2 Nothing in this Agreement precludes either of the Parties from fulfilling their respective mandates and obligations pursuant to their respective jurisdictions while the Parties reach a resolution or from taking such actions as may be deemed necessary in the event the Parties fail to reach a resolution.

12. OFFICIAL LANGUAGES

12.1 This Agreement is prepared in the English and French languages, and both versions are equally authoritative.

13. ENTIRE AGREEMENT

13.1 This Agreement shall constitute the entire and sole agreement between the Parties and shall supersede all other communications, negotiations and agreements between the Parties in relation to the purpose and subject matter of this Agreement.

IN WITNESS WHEREOF this Agreement has been executed on behalf of Canada by the federal Minister of the Environment, and on behalf of New Brunswick by the New Brunswick Minister of Environment and Local Government.

FOR THE GOVERNMENT OF CANADA

__________________________________________

The Honourable Leona Aglukkaq

Minister of the Environment

June 30, 2014

FOR THE GOVERNMENT OF NEW BRUNSWICK

___________________________________________

The Honourable Danny Soucy

Minister of Environment and Local Government

July 10, 2014

ANNEX A

THE PARTIES' ROLES AND RESPONSIBILITIES CONCERNING THE EFFLUENT REGULATORY REPORTING INFORMATION SYSTEM (ERRIS)

1. Roles and Responsibilities

• Working together, the Parties will

1.1 coordinate activities related to the ERRIS, such as the training of New Brunswick officials on the use and function of the system, and assign responsibility for carrying out those activities agreed to by the Parties;

1.2 exchange the information from their respective databases necessary to allow accurate transfers of regulatory information from the ERRIS into the New Brunswick wastewater database; and

1.3 jointly review the ERRIS once a year and propose improvements as necessary.

• Canada will

1.4 build, operate, modify and maintain the ERRIS to collect and store the information required to be reported under the WSER and the Approvals to Operate. Priority will be given to building the ERRIS modules necessary to enable WSER reporting requirements;

1.5 provide New Brunswick with training material for the ERRIS that outlines the requirements and specifications supporting the WSER reporting requirements; and

1.6 ensure the secure handling, storage and real-time access by the Parties of information submitted to the ERRIS.

2. Proposed Schedule for Development of the ERRIS

• As of June 2014, Canada is providing through the ERRIS

2.1 the use of the Environment Canada single window information management system as the point of access to the ERRIS for the establishment of ERRIS user accounts and user roles;

2.2 the online modules and associated interfaces necessary to complete the identification report, as per section 18 of the WSER; to complete the monitoring reports, as per section 19 of the WSER; to complete the combined sewer overflow reports as per section 20 of the WSER; to complete an application for a transitional authorization, as per section 25 and subsection 48(1) of the WSER; and to complete an application for a temporary authorization to deposit un-ionized ammonia as per section 35 and subsection 48(1) of the WSER;

2.3 the ability for the Manager to generate reports stored within the ERRIS to assess compliance of the WSER Regulated Community with WSER requirements; and

2.4 the ability for owners and operators of municipally, privately, provincially or federally owned or operated Wastewater Systems in New Brunswick operating under Approvals to Operate, to report identification report information as per the Approvals to Operate requirements.

• By September 30, 2014, Canada will endeavor to provide through the ERRIS

2.5 the ability for the Manager to enter the reporting requirements as established for each Wastewater System in the Approval to Operate. The list of wastewater substances of concern that can be collected by the ERRIS is presented in section 3;

2.6 the ability for Canada to maintain a list of wastewater substances of concern;

2.7 the ability for the owners and operators of municipally, privately, provincially or federally owned or operated Wastewater Systems in New Brunswick operating under Approvals to Operate to enter information online for requirements stipulated by the Approvals to Operate;

2.8 the ability to upload information into the ERRIS that is required under an Approval to Operate. The structure of the information upload will be determined by Canada in consultation with New Brunswick;

2.9 a method where the ERRIS would calculate the average concentrations for carbonaceous biochemical oxygen demand (CBOD) and suspended solids for the WSER monitoring report information required as per section 19 of the WSER from the multiple records of wastewater sampling test results that would be entered either online (as per section 2.7 of this Annex) or uploaded (as per section 2.8 of this Annex);

2.10 the ability to complete WSER monitoring reports, in addition to calculated average concentrations for CBOD and suspended solids as per section 2.9 of this Annex, by entering volume of effluent information, number of days effluent was deposited and months that effluent was not deposited for each reporting period, to complete the reporting requirements under section 19 of the WSER. The ERRIS will display the values calculated for CBOD and suspended solids (as per section 2.9 of this Annex) for each Wastewater System owner and operator to review and validate with an electronic signature, as per the requirements under section 19 of the WSER;

2.11 the ability for New Brunswick and the owners and operators of municipally, privately, provincially or federally owned or operated Wastewater Systems in New Brunswick operating under Approvals to Operate to access and view the information required by the Approvals to Operate that was entered or uploaded into the ERRIS;

2.12 the ability to download the information stored in the ERRIS required by the Approvals to Operate to a New Brunswick information management system. This download would be necessary if New Brunswick desires to process or analyze the information. The software format for this download will be agreed upon by the Parties;

2.13 the ability for New Brunswick to generate reports within the ERRIS that will assist New Brunswick in assessing compliance with the Approvals to Operate; and

2.14 the ability for applications for temporary bypass authorizations to be submitted as per section 44 and subsection 48(1) of the WSER.

• Beginning in January 2015, Canada will endeavor to provide through the ERRIS:

2.15 the ability for the results of testing for acute lethality and un-ionized ammonia to be submitted as per subparagraphs 19(1)(b)(vii) and (viii) of the WSER.

3. List of substances for which data can be collected by the ERRIS as per the Approvals to Operate

Test Group	Substances
General Chemistry / Nutrients	Fluoride Nitrate Nitrate + Nitrite Total Ammonia Nitrogen Total Nitrogen Total Kjeldahl Nitrogen (TKN) Total Phosphorus (TP) Suspended Solids Carbonaceous Biochemical Oxygen Demand (CBOD5) Biochemical Oxygen Demand (BOD5) Total Ammonia Un-ionized Ammonia (calculated) Total Residual Chlorine (TRC) Chemical Oxygen Demand (COD) Cyanide (total) pH Temperature Conductivity at 25°C Salinity Alkalinity Bicarbonate Calcium Carbonate Chloride Chlorophyll-a Dissolved Organic Carbon Dissolved Oxygen Magnesium Ortho Phosphorus Phenols Phosphates Potassium Sodium Sulfate Total Hardness Total Dissolved Solids
Metals	Aluminum Antimony Arsenic Barium Beryllium Boron Cadmium Chromium Cobalt Copper Iron Lead Manganese Mercury Molybdenum Nickel Selenium Silver Strontium Thallium Tin Titanium Uranium Vanadium Zinc
Pathogens	E. coli Total Coliform Bacteria Fecal Coliform Bacteria Fecal Streptococci Bacteria
Organochlorine Pesticides	Alpha-BHC Endosulfan (I and II) Endrin Heptachlor epoxide Lindane (gamma-BHC) Mirex DDT Methoxychlor Aldrin Dieldrin Heptachlor alpha-Chlordane gamma-Chlordane Toxaphene
Polychlorinated Biphenyls (PCBs)	Total PCBs
Polycyclic Aromatic Hydrocarbons (PAHs)	Acenaphthene Acenaphthylene Anthracene Benzo(a)anthracene Benzo(a)pyrene Benzo(b)fluoranthene Benzo(g,h,i,)perylene Benzo(k)fluoranthene Chrysene Dibenz(a,h)anthracene Fluoranthene Fluorine Indeno(1,2,3-cd)pyrene Methylnaphthalene Naphthalene Phenanthrene Pyrene
Volatile Organic Compounds (VOCs)	Benzene Bromodichloromethane Bromoform Carbon tetrachloride Chlorobenzene Chlorodibromomethane Chloroform 1,2-Dichlorobenzene 1,4-Dichlorobenzene 1,2-Dichloroethane 1,1-Dichloroethene Dichloromethane Ethylbenzene 1,1,1,2-Tetrachloroethane 1,1,2,2-Tetrachloroethane Tetrachloroethene Toluene Trichloroethene Vinyl chloride m/p-xylene o-Xylene
Phenolic Compounds	2,3,4,6-Tetrachlorophenol 2,4,6-Trichlorophenol 2,4-Dichlorophenol Pentachlorophenol
Surfactants	Non-ionic surfactants and anionic surfactants

4. Costs and Expenditures

4.1 Canada will be responsible for all costs of building, operating, modifying and maintaining the ERRIS modules that are or would be required for the collection of the information required to be reported under the WSER and the Approvals to Operate during the term of this Agreement.

4.2 New Brunswick will be responsible for all costs related to the management of the WSER-related information collected through the ERRIS, once this information is downloaded to the New Brunswick information management system.

4.3 New Brunswick will be responsible for all costs related to the management of the Approvals to Operate information collected through the ERRIS, once this information is downloaded to the New Brunswick information management system.

ANNEX B

TERMS OF REFERENCE FOR THE MANAGEMENT COMMITTEE FOR THE ADMINISTRATIVE AGREEMENT BETWEEN THE GOVERNMENT OF CANADA AND THE GOVERNMENT OF NEW BRUNSWICK REGARDING THE ADMINISTRATION OF THE WASTEWATER SYSTEMS EFFLUENT REGULATIONS

1. Members

1.1 The Management Committee will be jointly chaired by a representative of the wastewater program, Environment Canada, for Canada and by the Manager for New Brunswick.

1.2 The Management Committee will include an equal number of representatives from Canada and New Brunswick, and include one representative from the enforcement office of Environment Canada for Canada and one representative from the enforcement office of the New Brunswick Department of Environment and Local Government for New Brunswick, appointed respectively by the Parties.

1.3 A Party may appoint alternates as per section 5.2 of this Annex.

1.4 Co-chairpersons, representatives and alternates will be considered members of the Management Committee.

2. Responsibilities

The Management Committee is responsible for

2.1 overseeing the implementation of this Agreement;

2.2 establishing all procedures required to effectively administer this Agreement, including, but not exclusively, those pertaining to cooperation on enforcement and those ensuring that all relevant information is requested and provided appropriately to meet the timing requirements of both Parties in accordance with this Agreement;

2.3 facilitating the complete and timely exchange of information relevant to this Agreement in accordance with relevant sections of this Agreement;

2.4 administering and adhering to the financial provisions of this Agreement;

2.5 making recommendations to the Parties regarding any amendments to this Agreement that may be required;

2.6 establishing a concerted approach to the communication of information to the public and responses to media inquiries regarding this Agreement;

2.7 providing written recommendations to the Parties, taking into consideration the report referred to in section 8.2 of this Agreement, for any future potential agreement; and

2.8 resolving disputes which may arise between the Parties as described in section 11.1 of this Agreement.

3. Operation of the Committee

3.1 The Management Committee may create joint federal- provincial working groups that report to the Management Committee to assist it in the effective implementation and management of this Agreement.

3.2 All decisions of the Management Committee will be made on a consensus basis.

3.3 Notwithstanding the expiry or termination of this Agreement, the Management Committee will have six months to complete its activities following the expiry or termination of this Agreement.

3.4 Canada will hold the secretariat function for the Management Committee.

3.5 The Management Committee is to record in writing all items discussed during its meetings and all decisions taken.

3.6 Within the two weeks following every Management Committee meeting, the Secretariat will prepare minutes and transmit these minutes to the members of the Management Committee.

4. Public Communications

4.1 Where possible, public communications and media inquiries arising from the activities undertaken pursuant to this Agreement are to be co-ordinated by the co-chairpersons.

4.2 Where one co-chairperson responds to public communications and public inquiries without prior consultation with the other co-chairperson, the responding co-chairperson is to inform the other co-chairperson and other Committee members, as soon as possible.

5. Meetings

5.1 The Management Committee is to meet a minimum of two times per year to implement this Agreement, or upon the request of one of the Parties, at a place and time mutually agreed to by the co-chairpersons.

5.2 The Party who appointed the members to the Management Committee may authorize an alternate to replace a member at Management Committee meetings on an ad hoc basis.

[31-1-o]

DEPARTMENT OF HEALTH

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions, undertakings and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.

In accordance with section 20 of the Hazardous Materials Information Review Act, a claimant or any affected party may appeal a decision or order of a screening officer. An affected party may also appeal an undertaking in respect of which a notice has been published in the Canada Gazette. “Affected party” means a person who is not a competitor of the claimant and who uses, supplies or is otherwise involved in the use or supply of the controlled product at a work place, and includes

• (a) a supplier of the controlled product;
• (b) an employee at the work place;
• (c) an employer at the work place;
• (d) a safety and health professional for the work place;
• (e) a safety and health representative or a member of a safety and health committee for the work place; and
• (f) a person who is authorized in writing to represent
  • (i) a supplier referred to in paragraph (a) or an employer referred to in paragraph (c), or
  • (ii) an employee referred to in paragraph (b), except where that person is an official or a representative of a trade union that is not certified or recognized in respect of the work place.

To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered, along with the fee prescribed by section 12 of the Hazardous Materials Information Review Regulations, within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Workplace Hazardous Materials Directorate, 427 Laurier Avenue West, 7th Floor, Ottawa, Ontario K1A 0K9.

STEPHANIE REID
Chief Screening Officer

Claimant	Product Identifier (As shown on the MSDS)	Registry Number	Date of Decision
Power Service Products Inc., Weatherford, Texas	DIESEL 9·1·1	8371	2014-01-31
Afton Chemical Corporation, Richmond, Virginia	HiTEC 6597 Gasoline Fuel Additive	8464	2014-02-04
Chevron Oronite Company LLC, Bellaire, Texas	OLOA 9730D	8481	2014-03-27
3M Canada Company, London, Ontario	3M™ Super Weatherstrip and Gasket Adhesive - Black, P.N. 08008	8486	2014-01-28
Chevron Oronite Company LLC, Bellaire, Texas	OLOA 275JD	8493	2014-02-13
Schlumberger Canada Limited, Calgary, Alberta	Anti-Sludge Agent W58	8505	2014-02-20
Chemfax Products Ltd., Calgary, Alberta	MF SIL-SOAP	8508	2014-03-31
Momentive Performance Materials, Markham, Ontario	Niax® catalyst A-200	8551	2014-02-04
Momentive Performance Materials, Markham, Ontario	Silwet® 800	8554	2014-01-15
Momentive Performance Materials, Markham, Ontario	Niax® silicone Y-10900	8556	2014-02-05
Momentive Performance Materials, Markham, Ontario	Niax* silicone L-620	8580	2014-02-26
Ferro Corporation, Mayfield Heights, Ohio	Therm-Chek® 837 40 Lb Pail	8583	2014-02-12
3M Canada Company, London, Ontario	Scotchcast Electrical Resin 275	8584	2014-02-05
3M Canada Company, London, Ontario	3M™ AUTOMIX™ PANEL BONDING ADHESIVE, PART A (P.N. 08115)	8590	2014-02-12
Momentive Performance Materials, Markham, Ontario	Niax ® catalyst A-330	8595	2014-02-28
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® C-3082	8610	2014-03-03
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDISET® LQ-1102C	8611	2014-03-03
3M Canada Company, London, Ontario	3M™ Dynatron Liquid Hardener 609	8620	2014-03-27
3M Canada Company, London, Ontario	3M™ Bondo Traffic MEKP Hardener 5, 7	8621	2014-03-27
Abressa Canada Inc., Saint-Sébastien-de-Frontenac, Québec	SYNTER	8633	2014-03-19
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID™ KM-4400	8640	2014-02-26
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	POLYFAC™ E-660	8642	2014-01-15
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	PAVE BOND® LITE	8659	2014-02-05
Kop-Coat, St. Louis, Missouri	ENHANCE™ ACTIVATOR	8660	2014-03-24
Nalco Canada Co., Burlington, Ontario	NALCO® EC2670A	8662	2014-01-29
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	BEROL® 226 SA	8666	2014-03-24
GE Water & Process Technologies Canada, Oakville, Ontario	SPEC-AID BIO9101	8672	2014-02-14
GE Water & Process Technologies Canada, Oakville, Ontario	SPEC-AID BIO9400	8673	2014-02-14
Calfrac Well Services Ltd., Calgary, Alberta	DAP-111	8676	2014-02-05
Schlumberger Canada Limited, Calgary, Alberta	Iron Reducing Agent L073	8681	2014-03-13
Nalco Canada Co., Burlington, Ontario	BREAXIT® EC6048A	8687	2014-02-25
3M Canada Company, London, Ontario	3M™ SMC/Fiberglass Repair Adhesive-1 PN08270, Part A	8688	2014-03-31
3M Canada Company, London, Ontario	3M™ SMC/Fiberglass Repair Adhesive-1 PN08270, Part B	8689	2014-03-31
Calfrac Well Services Ltd., Calgary, Alberta	DWP-713	8694	2014-03-04
Baker Petrolite Corp., Sugar Land, Texas	RE7154RBW	8697	2014-01-13
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Redicote® C-2914	8698	2014-02-21
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Armeen® PF53W	8699	2014-02-12
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Armeen® PF-52Ho	8700	2014-02-12
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Redicote® E-64R E	8701	2014-03-04
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Berol® 508 SA	8702	2014-01-31
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Petro® BAF Powder	8703	2014-02-05
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Redicote® C-404	8704	2014-03-28
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Redicote® E-6945	8705	2014-01-31
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Redicote® RM-007A	8706	2014-02-21
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Redicote® E-7000	8708	2014-02-12
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Petro® 11 Powder	8709	2014-02-05
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Petro® BA Powder	8710	2014-02-05
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Armeen® PF-1	8711	2014-02-12
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Armeen® PF-3	8712	2014-02-12
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Witconate™ 1100	8713	2014-03-04
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	Redicote® E-15	8714	2014-03-13
DuPont Electronic Technologies-MCM, Raleigh, North Carolina	5025	8718	2014-01-15
DuPont Electronic Technologies-MCM, Raleigh, North Carolina	7102	8719	2014-01-16
DuPont Electronic Technologies-MCM, Raleigh, North Carolina	5524	8720	2014-01-15
DuPont Electronic Technologies-MCM, Raleigh, North Carolina	CB028	8721	2014-01-20
DuPont Electronic Technologies-MCM, Raleigh, North Carolina	7082	8722	2014-01-13
DuPont Electronic Technologies-MCM, Raleigh, North Carolina	7164	8723	2014-01-13
DuPont Electronic Technologies-MCM, Raleigh, North Carolina	5042	8724	2014-01-30
Nalco Canada Co., Burlington, Ontario	3D TRASAR® 3DT200	8726	2014-01-22
Baker Petrolite Corp., Sugar Land, Texas	PAO2349 PARAFFIN INHIBITOR	8728	2014-01-06
Baker Petrolite Corp., Sugar Land, Texas	CGW3361 CORROSION INHIBITOR	8729	2014-01-06
ClearTech Industries Inc., Saskatoon, Saskatchewan	FilterClean F	8733	2014-01-23
Baker Petrolite Corp., Sugar Land, Texas	CRO9141U CORROSION INHIBITOR	8737	2014-03-28
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	EnvaMul™ 1802	8738	2014-03-12
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	EnvaCor™ 653 HA	8739	2014-03-12
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	EnvaCor™ 653	8740	2014-03-12
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	EnvaCor™ 703	8741	2014-03-12
Trican Well Service Ltd., Calgary, Alberta	S-9	8743	2014-03-05
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	EnvaWet™ 653	8745	2014-03-12
Baker Petrolite Corp., Sugar Land, Texas	SULFIX™ 9200 SCAVENGER	8749	2014-01-29
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID™ BTA-751ER Impact Modifier	8750	2014-02-28
3M Canada Company, London, Ontario	3M™ Panel Bonding Adhesive PN 38315, 58115 - Part A	8751	2014-01-24
Nalco Canada Co., Burlington, Ontario	EC9382A Emulsion Breaker	8752	2014-02-03
Graffiti Solutions Canada, Ottawa, Ontario	Porous Surface Blaster Graffiti Remover	8760	2014-03-21
CRI/Criterion Inc., Houston, Texas	CRITERION CENTERA™ DN-3636 CATALYST	8761	2014-03-11
CRI/Criterion Inc., Houston, Texas	CRITERION CENTERA™ DC-Shell CATALYST	8762	2014-03-11
CRI/Criterion Inc., Houston, Texas	CRITERION CENTERA™ DN-3651A CATALYST	8763	2014-03-11
CRI/Criterion Inc., Houston, Texas	CRITERION CENTERA™ DC-2635 CATALYST	8764	2014-03-11
Baker Petrolite Corp., Sugar Land, Texas	PETROSWEET™ HSW31170 H2S SCAVENGER	8766	2014-01-28
Baker Petrolite Corp., Sugar Land, Texas	PETROSWEET™ HSW31250 H2S SCAVENGER	8767	2014-01-28
Suncor Energy Inc., Mississauga, Ontario	HYUNDAI GEARLUBE 75W85 GL-4	8768	2014-03-04
Suncor Energy Inc., Mississauga, Ontario	KIA 75W85 GEAROIL PART#99998-0777585	8769	2014-03-04
Nalco Canada Co., Burlington, Ontario	EC3261A ANTIFOULANT	8773	2014-02-03
INEOS Oxide LLC, Houston, Texas	GAS/SPEC* CS-2000* Additive	8774	2014-01-07
INEOS Oxide LLC, Houston, Texas	GAS/SPEC* CS-2010* Solvent	8775	2014-01-07
INEOS Oxide LLC, Houston, Texas	GAS/SPEC* CS-Plus* Solvent	8776	2014-01-07
Baker Petrolite Corp., Sugar Land, Texas	M2612	8777	2014-01-28
FC PRO, LLC, Waller, Texas	FCPRO Surfactant 400	8786	2014-03-04
Baker Petrolite Corp., Sugar Land, Texas	SCW2600 SCALE INHIBITOR	8794	2014-01-28
GE Water & Process Technologies Canada, Oakville, Ontario	MAX-AMINE GT741C	8795	2014-02-28
GE Water & Process Technologies Canada, Oakville, Ontario	DIMETALLIC 00U85	8796	2014-01-28
Baker Petrolite Corp., Sugar Land, Texas	TOLAD™ 9715 ADDITIVE	8801	2014-02-13
BYK USA Inc., Wallingford, Connecticut	Disperbyk-2150	8804	2014-03-13
Baker Petrolite Corp., Sugar Land, Texas	BPR 34363 ASPHALTENE DISPERSANT	8808	2014-02-12
Baker Petrolite Corp., Sugar Land, Texas	PAO2349X PARAFFIN INHIBITOR	8814	2014-02-25
3M Canada Company, London, Ontario	AHS-1517 bulk spray adhesive	8818	2014-03-26
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID™ KM-5450 IMPACT MODIFIER	8822	2014-03-21
Stepan Company, Northfield, Illinois	AGENT 2517-74N	8824	2014-02-26
Engenium Chemicals Corporation, Calgary, Alberta	CAN-2062	8826	2014-01-31
Engenium Chemicals Corporation, Calgary, Alberta	INTERPHON SODA	8827	2014-01-31
Engenium Chemicals Corporation, Calgary, Alberta	Blackstone Onyxmuls S	8828	2014-01-31
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	EVOTHERM™ R1	8829	2014-03-12
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	PERAL® 417	8830	2014-03-13
3M Canada Company, London, Ontario	3M™ FAST TACK WATER BASED ADHESIVE 1000NF, PURPLE	8833	2014-03-26
3M Canada Company, London, Ontario	3M™ FAST TACK WATER BASED ADHESIVE 1000NF, NEUTRAL	8834	2014-03-26
Univar Canada Ltd., Richmond, British Columbia	VANFROTH 820	8835	2014-02-14
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina	EVOTHERM™ Q1	8843	2014-03-13
Stepan Company, Northfield, Illinois	AGENT 3130-22	8847	2014-02-25
Stepan Company, Northfield, Illinois	PETROSTEP S-13D HA	8852	2014-02-14
3M Canada Company, London, Ontario	3M™ HEAVY DUTY MULTI-SURFACE CLEANER Concentrate (Twist 'n Fill™ Product No. 2)	8870	2014-03-10
Engenium Chemicals Corporation, Calgary, Alberta	ZX-102	8875	2014-03-27
Calfrac Well Services Ltd., Calgary, Alberta	DWP-124	8879	2014-03-24
BASF Canada Inc., Mississauga, Ontario	Plurafac® SLF 180	8909	2014-03-31

• NOTES: 1. The Notice of Filing published in the Canada Gazette, Part I, on December 3, 2011, listed the subject of the claim bearing Registry Number 8371 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
• 2. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the subject of the claim bearing Registry Number 8556 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision was the chemical identity of two ingredients.
• 3. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2012, listed the subject of the claim bearing Registry Number 8640 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
• 4. The Notice of Filing published in the Canada Gazette, Part I, on September 22, 2012, for the product bearing Registry Number 8659, listed the product identifier to be PAVEBOND® LITE and the subject of the claim to be the chemical identity of one ingredient. The product identifier and the subject of the claim for the product on which the screening officer issued the decision are PAVE BOND® LITE and the chemical identity of three ingredients, respectively.
• 5. The Notice of Filing published in the Canada Gazette, Part I, on September 22, 2012, for the product bearing Registry Number 8660, listed the location of the claimant to be Pittsburgh, Pennsylvania, and the subject of the claim to be the chemical identity of six ingredients. The location of the claimant and the subject of the claim for the product on which the screening officer issued the decision are St. Louis, Missouri, and the chemical identity of four ingredients, respectively.
• 6. The Notice of Filing published in the Canada Gazette, Part I, on December 1, 2012, for the products bearing Registry Numbers 8718, 8719, 8720 and 8722, listed the location of the claimant to be Raleigh, North Carolina. The location of the claimant on which the screening officer issued the decision is Research Triangle Park, North Carolina.
• 7. The Notice of Filing published in the Canada Gazette, Part I, on December 1, 2012, listed the subject of the claim bearing Registry Number 8733 to be the chemical identity and concentration of six ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of five ingredients.
• 8. The Notice of Filing published in the Canada Gazette, Part I, on December 1, 2012, listed the subject of the claim bearing Registry Number 8738 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
• 9. The Notice of Filing published in the Canada Gazette, Part I, on December 1, 2012, listed the subject of the claim bearing Registry Number 8761 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
• 10. The Notice of Filing published in the Canada Gazette, Part I, on December 1, 2012, for the product bearing Registry Number 8762, listed the product identifier to be Criterion Centera ™ DC-Shell Catalyst and the subject of the claim to be the chemical identity of two ingredients. The product identifier and the subject of the claim for the product on which the screening officer issued the decision are Centera ™ DC-Shell Catalyst and the chemical identity of one ingredient, respectively.
• 11. The Notice of Filing published in the Canada Gazette, Part I, on February 23, 2013, listed the product identifier for the product bearing Registry Number 8827 to be INTERPHONE SODA. The product identifier for the product on which the screening officer issued the decision is INTERPHON SODA.
• 12. The Notice of Filing published in the Canada Gazette, Part I, on February 23, 2013, listed the subject of the claim bearing Registry Number 8829 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
• 13. The Notice of Filing published in the Canada Gazette, Part I, on February 23, 2013, for the product bearing Registry Number 8830, listed the product identifier to be PERAL™ 417 and the subject of the claim to be the chemical identity and concentration of one ingredient. The product identifier and the subject of the claim for the product on which the screening officer issued the decision are PERAL® 417 and the chemical identity of one ingredient, respectively.

There were no written representations from affected parties to the screening officer with respect to any of the above-mentioned claims for exemption and related MSDSs or labels.

Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDSs in respect of the claims bearing Registry Numbers 8493, 8697, 8702, 8703, 8704, 8705, 8709, 8721, 8723, 8724, 8750, 8760, 8768, 8769, 8774, 8775, 8776, 8796, 8801, 8808, 8814, 8822, 8847, 8870, 8879 complied with the applicable requirements of the Hazardous Products Act and the Controlled Products Regulations.

In the case of the claims bearing Registry Numbers 8505 and 8681, being claims from an employer with operations in the province of Alberta, the screening officer found that the MSDSs and labels in respect of which the claims were filed did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code 2009 of the Province of Alberta.

In all cases where the MSDS or the label was determined not to be in compliance with the relevant legislation, the screening officer offered the claimant the possibility of entering into an undertaking whereby the claimant would voluntarily make the changes necessary to bring the MSDS or the label into compliance. Pursuant to subsection 16.1(1) of the Hazardous Materials Information Review Act, the claimant was given 30 days to provide the screening officer with a signed undertaking accompanied by the MSDS or the label amended as necessary.

In the case of the following claims, the claimant supplied the screening officer with a signed undertaking accompanied by the MSDS or label amended as necessary within the time frame specified. The screening officer was satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified therein.

CLAIMS FOR WHICH THE SCREENING OFFICER WAS SATISFIED THAT THE CLAIMANT HAD TAKEN THE MEASURES SET OUT IN THE UNDERTAKING

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of information that has been disclosed on the relevant MSDS or label in compliance with an undertaking.

Registry Number 8371

Date of notice confirming acceptance: March 3, 2014

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the percent concentration for two of the confidential hazardous ingredients in the controlled product, in an acceptable manner.
2. Disclose the percent concentration for hazardous ingredients “n-butanol” and “xylenes” in the controlled product, in an acceptable manner.
3. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 15–20 minutes or until the chemical is removed, and a statement to the effect that contaminated clothing, shoes and leather goods should be removed.
4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
5. In relation to the personal protective equipment information shown on the MSDS, disclose that chemical / oil resistant clothing and gloves should be worn at all times when handling the product.
6. Disclose an LD₅₀ (dermal, rabbit) value of >1 g/kg for the ingredient “aliphatic hydrocarbon 4”.
7. Disclose that exposure to ingredients in the controlled product has been shown to cause teratogenic and embryotoxic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8481

Date of notice confirming acceptance: April 22, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose the presence of two additional hazardous ingredients in the controlled product together with their chemical identities, percent concentration and CAS registry numbers, in an acceptable manner.

Registry Number 8486

Date of notice confirming acceptance: March 3, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the presence of two additional hazardous ingredients in the controlled product together with their chemical identities, percent concentration and CAS registry numbers, in an acceptable manner.
2. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 20 minutes or until the chemical is removed.
3. In relation to the first aid information shown on the MSDS for inhalation and ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
4. Add hydrogen chloride to the list of hazardous combustion products.
5. Disclose a statement to the effect that the product should be stored in a cool and dry location.
6. Disclose an ACGIH TLV–TWA Exposure Limit of 3 mg/m³ for the hazardous ingredient “carbon black”.

Registry Number 8505

Date of notice confirming acceptance: April 3, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8551

Date of notice confirming acceptance: March 5, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.
2. Disclose that an ingredient in the controlled product has been shown to cause skin corrosion.
3. Disclose inhalation as a route of exposure.
4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: do not induce vomiting, but if vomiting should occur naturally, have the casualty lie on their side, in the recovery position, and obtain medical attention immediately.
5. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water and that medical attention must be obtained immediately.
6. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.
7. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredients “Tertiary amines #1” and “Tertiary amines #2”, in an acceptable manner.
8. Disclose an LD₅₀ (dermal, rabbit) value of 1.41 mL/kg for the confidential hazardous ingredient “Tertiary amines #1”.

Registry Number 8554

Date of notice confirming acceptance: February 19, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

Registry Number 8556

Date of notice confirming acceptance: March 10, 2014

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration, and obtain medical attention immediately.

Registry Number 8580

Date of notice confirming acceptance: April 8, 2014

The claimant had been advised to amend certain aspects of the content and format of the MSDS.

Registry Number 8583

Date of notice confirming acceptance: March 18, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion in laboratory animals.
2. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

Registry Number 8584

Date of notice confirming acceptance: March 12, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose the International Agency for Research on Cancer (IARC) Group 2B classification for hazardous ingredient “2-methylimidazole”.
2. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 20 minutes.
3. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lung effects in laboratory animals.
4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro.

Registry Number 8590

Date of notice confirming acceptance: March 25, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (dermal, rabbit) value of 0.88 mL/kg for the hazardous ingredient “N-aminoethylpiperazine”.

Registry Number 8595

Date of notice confirming acceptance: March 26, 2014

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.
2. Disclose an LD₅₀ (oral, rat) value of 700 mg/kg for the hazardous ingredient “triethylenediamine”.

Registry Number 8620

Date of notice confirming acceptance: April 28, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the percent concentration of hazardous ingredient “methyl ethyl ketone” in the controlled product, in an acceptable manner.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
3. Disclose an LD₅₀ (oral, rat) value of 484 mg/kg for the hazardous ingredient “methyl ethyl ketone”.
4. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “benzoic acid derivative”, in an acceptable manner.
5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro.
6. Disclose that hazardous ingredients in the controlled product have been shown to cause reproductive, fetotoxic and teratogenic effects in laboratory animals.

Registry Number 8621

Date of notice confirming acceptance: April 28, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose the percent concentration of the hazardous ingredient “methyl ethyl ketone” in the controlled product, in an acceptable manner.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
3. Disclose an LD₅₀ (oral, rat) value of 484 mg/kg for the hazardous ingredient “methyl ethyl ketone”.
4. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “benzoic acid derivative”, in an acceptable manner.
5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro.
6. Disclose that hazardous ingredients in the controlled product have been shown to cause reproductive, fetotoxic and teratogenic effects in laboratory animals.

Registry Number 8633

Date of notice confirming acceptance: April 4, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that ingestion of an ingredient in the controlled product has been shown to cause kidney effects in laboratory animals.
2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
3. Disclose that exposure to an ingredient in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.
4. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 20 minutes or until the chemical is removed.
5. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
6. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water to drink.
7. Disclose an ACGIH TVL–TWA Exposure Limit of 5 ppm, with a skin notation, for the confidential hazardous ingredient “aromatic hydrocarbon hydroxyl”.
8. Disclose an LD₅₀ (oral, rat) value of 340 mg/kg and an LD₅₀ (dermal, rabbit) value of 630 mg/kg for the confidential hazardous ingredient “aromatic hydrocarbon hydroxyl”.
9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

Registry Number 8640

Date of notice confirming acceptance: March 21, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8642

Date of notice confirming acceptance: February 24, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8659

Date of notice confirming acceptance: February 28, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product, together with their percent concentration, in an acceptable manner.

Registry Number 8660

Date of notice confirming acceptance: April 3, 2014

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, rat) value of 1 320 mg/kg for the confidential hazardous ingredient “methyl amine 1”.
2. Disclose the AIHA WEEL–TWA Exposure Limit value of 250 ppm for the hazardous ingredient “dimethyl sulfoxide”.

Registry Number 8662

Date of notice confirming acceptance: March 10, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in humans.
2. Disclose an LD₅₀ (oral, rat) value of >1 000 mg/kg for the confidential hazardous ingredients “organic sulfonic acid salt” and “oxyalkylated alcohol A”.
3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
4. Add oxides of sulphur and hydrogen chloride to the list of hazardous combustion products.

Registry Number 8672

Date of notice confirming acceptance: March 11, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

Registry Number 8673

Date of notice confirming acceptance: March 11, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, female rat) value of 272 mg/kg for the hazardous ingredient “N,N-Dimethylcyclohexylamine”.
2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

Registry Number 8676

Date of notice confirming acceptance: February 19, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration and never give anything by mouth.
3. Disclose an LD₅₀ (oral, rat) value for one of the confidential hazardous ingredients, in an acceptable manner.

Registry Number 8687

Date of notice confirming acceptance: April 2, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, in an acceptable manner.
2. Disclose an LD₅₀ (oral, female rat) value and an LD₅₀ (dermal, female rabbit) value for the confidential hazardous ingredient “glycol ether”, in an acceptable manner.
3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that medical attention must be obtained immediately.
4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class B3.

Registry Number 8688

Date of notice confirming acceptance: May 2, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, in an acceptable manner.
2. Disclose the percent concentration for the confidential hazardous ingredients “methylene phenylene isocyanate” and “diisocyanate polymer” in the controlled product, in an acceptable manner.

Registry Number 8689

Date of notice confirming acceptance: May 2, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the percent concentration for the hazardous ingredient “piperazine” in the controlled product, in an acceptable manner.

Registry Number 8694

Date of notice confirming acceptance: March 31, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 60 minutes.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: if vomiting should occur naturally have the casualty lie on their side, in the recovery position.
3. Disclose an LD₅₀ (oral, rat) value of 1 145 mg/kg for the controlled product.

Registry Number 8726

Date of notice confirming acceptance: February 25, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that the controlled product may cause eye and skin corrosion.
2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration; if the casualty is rapidly losing consciousness, convulsing or is unconscious, vomiting should not be induced and fluids should not be offered to drink.
4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

Registry Number 8728

Date of notice confirming acceptance: January 20, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause teratogenic effects in the absence of maternal toxicity in laboratory animals.

Registry Number 8729

Date of notice confirming acceptance: January 6, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose ingestion as a route of entry.
2. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion.
3. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.
4. Add hydrogen chloride to the list of hazardous combustion products.

Registry Number 8733

Date of notice confirming acceptance: February 26, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose an ACGIH TLV–TWA Exposure Limit of 1 mg/m³ and an ACGIH TLV–STEL Exposure Limit of 3 mg/m³ for the confidential hazardous ingredient “acid D”.
2. Disclose an ACGIH TLV–C Exposure Limit of 2 ppm for the confidential hazardous ingredient “acid E”.
3. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes or until the chemical is removed and that medical attention must be obtained immediately.
4. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.
5. Add oxides of carbon, oxides of sulphur and hydrogen chloride to the list of hazardous decomposition products.
6. Disclose an LD₅₀ (oral, mouse) value of 5 400 mg/kg for the confidential hazardous ingredient “acid B”.
7. Disclose an LD₅₀ (oral, rat) value of 1 938 mg/kg and an LC₅₀ (aerosol, male rat, 4 hours) value of 3.6 mg/L for the confidential hazardous ingredient “acid C”.
8. Disclose an LD₅₀ (oral, rat) value of 4 400 mg/kg for the confidential hazardous ingredient “acid D”.
9. Disclose an LD₅₀ (oral, female rat) value of 238–277 mg/kg, an LC₅₀ (aerosol, rat, 4 hours) value of 8.3 mg/L or 1 040 mg/m³, and an LC₅₀ (aerosol, mouse, 4 hours) value of 3.2 mg/L or 400 mg/m³ for the confidential hazardous ingredient “acid E”.
10. Disclose that exposure to an ingredient in the controlled product has been shown to cause developmental toxicity in the presence of maternal toxicity in laboratory animals.

Registry Number 8737

Date of notice confirming acceptance: April 22, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion in laboratory animals.
2. Disclose ingestion as a route of entry.
3. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.
4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
5. Add hydrogen chloride to the list of hazardous combustion products.
6. Disclose an ACGIH TVL–TWA Exposure Limit of 200 mg/m³, with a skin notation, for the hazardous ingredient “kerosene”.
7. Disclose an LD₅₀ (oral, rat) value of 239 mg/kg for the hazardous ingredient “pyridinium, 1-(phenylmethyl)-, alkyl derivs., chlorides”.

Registry Number 8738

Date of notice confirming acceptance: April 24, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that the hazardous ingredients “fatty amidoamine” and “proprietary fatty acid” in the controlled product have been shown to cause skin sensitization in laboratory animals.
2. Disclose the presence of four additional confidential hazardous ingredients in the controlled product together with their chemical identity and percent concentration, in an acceptable manner.
3. Disclose an LD₅₀ (oral, rat) and (dermal, rabbit) value for the hazardous ingredient “glycol monoalkyl ether”, in an acceptable manner.

Registry Numbers 8739, 8740, 8741 and 8745

Date of notice confirming acceptance: April 24, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

Registry Number 8743

Date of notice confirming acceptance: March 28, 2014

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that ingestion of an ingredient in the controlled product has been shown to cause renal failure in humans.
2. Disclose an LD₅₀ (oral, rat) value of >500 mg/kg for the confidential hazardous ingredients “quaternary ammonium compound 1” and “quaternary ammonium compound 2”.

Registry Number 8749

Date of notice confirming acceptance: February 19, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose ingestion as a route of entry.
2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacteria, in vitro.

Registry Number 8751

Date of notice confirming acceptance: February 24, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration and obtain medical attention immediately.
3. Add oxides of nitrogen to the list of hazardous combustion products.
4. Disclose an LD₅₀ (dermal, rabbit) value for the confidential hazardous ingredient “N-aminoethylpiperazine”, in an acceptable manner.

Registry Number 8761

Date of notice confirming acceptance: April 23, 2014

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the percent concentration for the hazardous ingredients “aluminum oxide”, “phosphorus pentoxide”, “nickel oxide” and “glycol derivative” in the controlled product, in an acceptable manner.
2. Disclose an ACGIH TLV–TWA Exposure Limit of 0.5 mg/m³ (respirable) for the hazardous ingredient “molybdenum oxide” and that the hazardous ingredient “molybdenum oxide” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).
3. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “glycol derivative”, in an acceptable manner.
4. Disclose that an ingredient in the controlled product is an eye irritant in laboratory animals.
5. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.
6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause alveolar/bronchiolar adenoma or carcinoma in laboratory animals.
7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 8762

Date of notice confirming acceptance: April 23, 2014

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the percent concentration for the hazardous ingredients “aluminum oxide”, “molybdenum oxide”, “phosphorus pentoxide” and “glycol derivative” in the controlled product, in an acceptable manner.
2. Disclose that the hazardous ingredient “cobalt oxide” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).
3. Disclose an ACGIH TLV–TWA Exposure Limit of 0.5 mg/m³ (respirable) for the hazardous ingredient “molybdenum oxide” and that the hazardous ingredient “molybdenum oxide” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).
4. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “glycol derivative”, in an acceptable manner.
5. Disclose an LD₅₀ (oral, rat) value of 202 mg/kg and an LC₅₀ (rat, 4 hours) value of 0.06 mg/L for the hazardous ingredient “cobalt oxide”.
6. Disclose that an ingredient in the controlled product is an eye irritant in laboratory animals.
7. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause alveolar/bronchiolar adenoma or carcinoma in laboratory animals.
8. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2B and D1A.

Registry Number 8764

Date of notice confirming acceptance: April 23, 2014

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the percent concentration for the hazardous ingredients “aluminum oxide”, “phosphorus pentoxide”, “glycol derivative” and “substituted lactam” in the controlled product, in an acceptable manner.
2. Disclose that the hazardous ingredient “cobalt oxide” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).
3. Disclose an ACGIH TLV–TWA Exposure Limit of 0.5 mg/m³ (respirable) for the hazardous ingredient “molybdenum oxide” and that the hazardous ingredient “molybdenum oxide” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).
4. Disclose an LD₅₀ (oral, rat) value of 202 mg/kg and an LC₅₀ (rat, 4 hours) value of 0.06 mg/L for the hazardous ingredient “cobalt oxide”.
5. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “glycol derivative”, in an acceptable manner.
6. Disclose that an ingredient in the controlled product is an eye irritant in rabbits.
7. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause alveolar/bronchiolar adenoma or carcinoma in laboratory animals.
8. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.
9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2B and D1A.

Registry Number 8766

Date of notice confirming acceptance: February 19, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose ingestion as a route of entry.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped and should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.
3. Add hydrogen chloride to the list of hazardous combustion products.
4. Disclose an LD₅₀ (oral, rat) value of 763 mg/kg for the hazardous ingredient “2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol”.
5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacteria, in vitro.

Registry Number 8767

Date of notice confirming acceptance: February 19, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose ingestion as a route of entry.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
3. Add hydrogen chloride to the list of hazardous combustion products.
4. Disclose an LD₅₀ (oral, rat) value of 763 mg/kg for the hazardous ingredient “2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol”.
5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacteria, in vitro.

Registry Number 8777

Date of notice confirming acceptance: February 19, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose an AIHA WEEL–TWA Exposure Limit of 1 ppm, with a skin notation, for the hazardous ingredient “triethylenetetramine”.

Registry Number 8794

Date of notice confirming acceptance: February 19, 2014

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose ingestion as a route of entry.
2. Add hydrogen chloride to the list of hazardous combustion products.
3. Disclose an LD₅₀ (oral, rat) value of 1 220 mg/kg for the hazardous ingredient “ammonium chloride”.
4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mouse lymphoma assay.

Registry Number 8795

Date of notice confirming acceptance: March 31, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (dermal, rabbit) value of 13.30 mL/kg for the hazardous ingredient “polyol”.
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give three to four glasses of milk or water to drink.
3. Disclose an ACGIH TLV–TWA Exposure Limit of 10 ppm for the hazardous ingredient “diethylene glycol monobutyl ether”.
4. Disclose that hazardous ingredients in the controlled product have been shown to cause teratogenic effects in laboratory animals.

Registry Number 8804

Date of notice confirming acceptance: April 3, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose the LD₅₀ (oral, rat) values for all hazardous ingredients in the controlled product, in an acceptable manner.

Registry Number 8818

Date of notice confirming acceptance: April 22, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

Registry Number 8824

Date of notice confirming acceptance: March 11, 2014

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that acute dermal exposure to ingredients in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.
2. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 20 minutes or until the chemical is removed.
3. Add oxides of carbon to the list of hazardous combustion products.
4. Disclose an LD₅₀ (oral, female rat) value of 720 mg/kg and an LD₅₀ (dermal, rabbit) value of 2 330 mg/kg for the hazardous ingredient “1-hexanol”.
5. Disclose an LD₅₀ (oral, female rat) value of 7 050 mg/kg for the hazardous ingredient “solvent, naphtha, petroleum, heavy arom”.

Registry Number 8826

Date of notice confirming acceptance: March 3, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that acute inhalation of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects, lung effects and respiratory effects in laboratory animals.
2. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.
3. Disclose that oral and inhalation exposure to an ingredient in the controlled product has been shown to cause teratogenic/embryotoxic effects in the presence of maternal toxicity in laboratory animals.
4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
5. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product; that the product should be stored away from ignition sources and heat; and that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.
6. Disclose a statement to the effect that the product should be stored in a cool location away from any ignition sources.
7. Disclose an ACGIH TLV–TWA Exposure Limit of 10 ppm for the confidential hazardous ingredient “organic acid”.
8. Add oxides of sulphur to the list of hazardous combustion products.
9. Disclose a lower LD₅₀ (dermal, rabbit) value of 6.28 g/kg for the hazardous ingredient “2-propanol”.
10. Disclose an LD₅₀ (oral, rat) value of >500 mg/kg and an LC₅₀ (vapour, mouse, 4 hours) value of >2 500 ppm for the confidential hazardous ingredient “organic acid”.

Registry Number 8827

Date of notice confirming acceptance: March 3, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that inhalation of an ingredient in the controlled product has been shown to cause central nervous system (CNS) and lung effects in laboratory animals.
2. Disclose that ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in humans.
3. Disclose that oral and inhalation exposure to an ingredient in the controlled product has been shown to cause teratogenic/embryotoxic effects in the presence of maternal toxicity in laboratory animals.
4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
5. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product.
6. Disclose a statement to the effect that the product should be stored in a cool location away from any ignition sources.
7. Add oxides of nitrogen to the list of hazardous combustion products.
8. Disclose a lower LD₅₀ (dermal, rabbit) value of 6.28 g/kg for the hazardous ingredient “2-propanol”.

Registry Number 8828

Date of notice confirming acceptance: March 3, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose that the confidential hazardous ingredients “modified tall oil fatty acid 1” and “modified tall oil fatty acid 2” in the controlled product have been shown to cause skin sensitization in laboratory animals.
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two to three glasses of water to drink.
3. Disclose an ACGIH TLV–TWA Exposure Limit of 10 ppm (inhalable fraction and vapour) for the hazardous ingredient “diethylene glycol monobutyl ether”.

Registry Number 8829

Date of notice confirming acceptance: April 24, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

Registry Number 8830

Date of notice confirming acceptance: April 24, 2014

The claimant had been advised to amend certain aspects of the wording of the MSDS.

Registry Numbers 8833 and 8834

Date of notice confirming acceptance: April 22, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

Registry Number 8835

Date of notice confirming acceptance: March 5, 2014

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “glycol ether”, in an acceptable manner.
2. Disclose an ACGIH TVL–TWA Exposure Limit with a skin notation for the confidential hazardous ingredient “alcohol A”.

Registry Number 8843

Date of notice confirming acceptance: April 24, 2014

The claimant had been advised to amend certain aspects of the wording of the MSDS.

Registry Number 8852

Date of notice confirming acceptance: February 26, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Add oxides of carbon to the list of hazardous decomposition products.

Registry Number 8875

Date of notice confirming acceptance: April 4, 2014

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that inhalation of an ingredient in the controlled product has been shown to cause teratogenic/embryotoxic effects in the presence of maternal toxicity in laboratory animals.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
3. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product and that the product should be stored in a well-ventilated, cool, and dry location away from any ignition sources.
4. Disclose an ACGIH TVL–TWA Exposure Limit of 100 ppm for the confidential hazardous ingredient “alkanol”.
5. Add oxides of nitrogen to the list of hazardous combustion products.
6. Disclose an LD₅₀ (oral, rat) value of >500 mg/kg and an LD₅₀ (dermal, rabbit) value of >1 000 mg/kg for the confidential hazardous ingredient “alkanol”.

Registry Number 8909

Date of notice confirming acceptance: April 30, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give 200–300 mL of water to drink.

In the case of the following claims, either the claimant did not supply the screening officer with a signed undertaking or the screening officer was not satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified in it. Pursuant to subsection 17(1) of the Hazardous Materials Information Review Act, the screening officer ordered the claimant to comply with the requirements of the relevant legislation within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 30 days of expiry of the appeal period.

CLAIMS FOR WHICH THE SCREENING OFFICER ORDERED THE CLAIMANT TO COMPLY WITH THE APPLICABLE DISCLOSURE REQUIREMENTS

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of information that the screening officer ordered to be disclosed on an MSDS or a label reviewed by the screening officer.

Registry Number 8464

Date of order: March 10, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the presence of two additional hazardous ingredients in the controlled product together with their chemical identities, percent concentration and CAS registry numbers, in an acceptable manner.
2. Add oxides of nitrogen to the list of hazardous decomposition products.
3. Disclose an LD₅₀ (oral, rat) value and an LD₅₀ (dermal, rabbit) value for an additional hazardous ingredient in the controlled product, in an acceptable manner.

Registry Number 8508

Date of order: May 2, 2014

The claimant had been advised to amend certain aspects of the format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement such as the following: avoid direct contact; wear chemical protective gloves, if necessary; if contact lenses are present, do not delay irrigation or attempt to remove the lenses; if sterile 1% “calcium gluconate” solution is available, limit water flushing to 5 minutes, then use the 1% “calcium gluconate” solution to repeatedly rinse the eye(s); do not use “benzalkonium chloride” solution for eye contact.
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement such as the following: avoid direct contact; wear chemical protective clothing, if necessary; limit flushing with water to 5 minutes if a sterile 0.13% “benzalkonium chloride” solution or a sterile 2.5% “calcium gluconate” solution is available. If these treatments are not available, continue flushing until medical attention is available; immediately after thorough washing, either apply soakes of iced 0.13% “benzalkonium chloride” solution (changing every 2–4 minutes) or 2.5% “calcium gluconate” solution gel every 15 minutes and massage continuously until pain subsides and/or redness disappears or until medical attention becomes available.
3. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should administer a nebulized solution of 2.5% “calcium gluconate” with oxygen.
4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that medical attention must be obtained immediately.
5. Disclose an ACGIH TLV–TWA Exposure Limit with a skin notation for a hazardous ingredient in the controlled product, in an acceptable manner.
6. Disclose the LD₅₀/LC₅₀ values for the confidential hazardous ingredient “mineral acid # 2”, in an acceptable manner.

Registry Number 8610

Date of order: April 4, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause neurological effects in humans and central nervous system (CNS) effects in laboratory animals.
2. Disclose that the hazardous ingredient “proprietary fatty acids” in the controlled product has been shown to cause skin sensitization in laboratory animals.
3. Disclose ingestion as a route of entry.
4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
5. Disclose an AIHA WEEL–TWA Exposure Limit of 10 mg/m³ for the confidential hazardous ingredient “glycol”.
6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 8611

Date of order: April 4, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause neurological effects in humans and central nervous system (CNS) effects in laboratory animals.
2. Disclose ingestion as a route of entry.
3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
4. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “proprietary alkoxylated fatty polyamines”, in an acceptable manner.
5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 8666

Date of order: April 24, 2014

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Add oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.

Registry Number 8681

Date of order: April 16, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS and label. The claimant had been further advised to amend the MSDS and label as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1A, D2B and E.
2. If the WHMIS pictograms are shown on the MSDS and label, disclose the WHMIS E pictogram.
3. In relation to the first aid information shown on the MSDS and label for skin contact, disclose an approximate flush time of 30 minutes.
4. In relation to the first aid information shown on the MSDS and label for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lie on their side, in the recovery position, in order to reduce the risk of aspiration.
5. In relation to the first aid information shown on the MSDS and label for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
6. Disclose the AIHA WEEL–TWA Exposure Limit value of 0.2 ppm with a skin notation for the confidential hazardous ingredient “organic sulphur compound”.
7. Add hydrogen chloride to the list of hazardous decomposition products.
8. Disclose an LD₅₀ (oral, mouse) value of 110 mg/kg for the hazardous ingredient “cupric chloride dihydrate”.
9. Disclose that chronic oral exposure to an ingredient in the controlled product has been shown to cause liver and spleen effects in laboratory animals.
10. The claimant had also been advised to amend the label to recommend personal protective equipment for safe handling of the product.

Registry Number 8698

Date of order: March 24, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the percent concentration for the confidential hazardous ingredients “fatty polyamines”, “glycol ether 2”, “glycol ether 3”, and “glycol 2” in the controlled product, in an acceptable manner.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lie on their side, in the recovery position, in order to reduce the risk of aspiration.

Registry Numbers 8699 and 8700

Date of order: March 14, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion.
2. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “fatty amines”, in an acceptable manner.

Registry Number 8701

Date of order: April 4, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose ingestion as a route of entry.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.
3. Disclose an ACGIH TVL–STEL Exposure Limit of 1 000 ppm for the hazardous ingredient “ethanol”.
4. Disclose that the hazardous ingredient “ethanol” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).

Registry Number 8706

Date of order: March 24, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the percent concentration for the confidential hazardous ingredient “proprietary fatty amines” in the controlled product, in an acceptable manner.

Registry Number 8708

Date of order: March 14, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion.
2. Disclose an LC₅₀ (aerosol, male rat, 4 hours) value for the confidential hazardous ingredient “proprietary acid”, in an acceptable manner.

Registry Number 8710

Date of order: March 10, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose skin contact as a route of entry.
2. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 15–20 minutes or until the chemical is removed and a statement to the effect that contaminated clothing, shoes and leather goods should be removed.
3. Disclose that an ingredient in the controlled product is a skin irritant.

Registry Number 8711

Date of order: March 14, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion.
2. Disclose skin contact as a route of entry.
3. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “fatty amines”, in an acceptable manner.

Registry Number 8712

Date of order: March 14, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion.
2. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “fatty amines”, in an acceptable manner.

Registry Number 8713

Date of order: April 4, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, rat) value for an additional hazardous ingredient in the controlled product, in an acceptable manner.
2. Disclose an LD₅₀ (dermal, rabbit) value of 8.0 mL/kg for the ingredient “isopropanol”.

Registry Number 8714

Date of order: April 16, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the percent concentration of the confidential hazardous ingredient “proprietary fatty amines” in the controlled product, in an acceptable manner.
2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lie on their side, in the recovery position, in order to reduce the risk of aspiration.

Registry Number 8718

Date of order: February 25, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Numbers 8719 and 8720

Date of order: February 25, 2014

The claimant had been advised to amend the MSDS as indicated below.

1. Disclose an LC₅₀ (aerosol, rat, 4 hours) value of 6 800 mg/m³ for the hazardous ingredient “carbon black”.
2. Disclose that the hazardous ingredient “carbon black” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH) and classified as a Group 2B carcinogen by the International Agency for Research on Cancer (IARC).

Registry Number 8722

Date of order: February 25, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose that the hazardous ingredient “carbon black” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH) and classified as a Group 2B carcinogen by the International Agency for Research on Cancer (IARC).
2. Disclose an ACGIH TLV–TWA Exposure Limit of 3 mg/m³ for the hazardous ingredient “carbon black”.

Registry Number 8752

Date of order: March 17, 2014

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, female rat) value of 7 050 mg/kg for the hazardous ingredient “heavy aromatic naphtha”.

Registry Number 8773

Date of order: March 17, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, female rat) value of 7 050 mg/kg for the hazardous ingredient “heavy aromatic naphtha”.

Registry Number 8786

Date of order: April 8, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink.

The product for the following claim was discontinued after the issuance of the statement of decisions but prior to the issuance of either a signed undertaking or signed orders. The screening officer has identified the following instances of non-compliance with the requirements of the relevant legislation.

Registry Number 8763

Date of statement of decision: March 11, 2014

The screening officer determined that certain aspects of the content and format of the MSDS were required to be amended. The screening officer also determined that amendments to the MSDS were required as indicated below.

1. Disclose the percent concentrations of the hazardous ingredients “aluminum oxide”, “molybdenum oxide”, “phosphorus pentoxide”, “nickel oxide”, “glycol derivative” and “substituted lactam” in the controlled product, in an acceptable manner.
2. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 20 minutes.
3. Disclose an ACGIH TLV–TWA Exposure Limit of 0.5 mg/m³ (respirable) for the hazardous ingredient “molybdenum oxide”.
4. Disclose the AIHA WEEL–TWA (8 hours) Exposure Limit value of 10 ppm with a skin notation for the confidential hazardous ingredient “substituted lactam”.
5. Disclose an LD₅₀ (oral, rat) value for the confidential hazardous ingredient “glycol derivative”, in an acceptable manner.
6. Disclose that an ingredient in the controlled product is an eye irritant in rabbits.
7. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause blurred vision and central nervous system (CNS) effects in humans.
8. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause alveolar/bronchiolar adenoma or carcinoma in laboratory animals.
9. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause atrophy and necrosis of the thymus, spleen and lymph nodes, and bone marrow hypoplasia in laboratory animals.
10. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

For the following claim the screening officer issued the decision that the claim for exemption was invalid. The screening officer has identified the following instances of non-compliance with the requirements of the relevant legislation.

Registry Number 8737

Date of order: March 28, 2014

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

1. Disclose the presence of four additional hazardous ingredients in the controlled product together with their chemical identities and percent concentration, in an acceptable manner.

[31-1-o]

DEPARTMENT OF INDUSTRY

RADIOCOMMUNICATION ACT

Notice No. SLPB-004-14 — Consultation on the Technical, Policy and Licensing Framework for Advanced Wireless Services in the Bands 1755-1780 MHz and 2155-2180 MHz (AWS-3)

The intent of this notice is to announce a public consultation through Industry Canada's document entitled Consultation on the Technical, Policy and Licensing Framework for Advanced Wireless Services in the Bands 1755-1780 MHz and 2155-2180 MHz (AWS-3). This document sets out the Department's proposals with respect to the technical, policy and licensing framework for Advanced Wireless Services (AWS) in the bands 1755-1780 MHz and 2155-2180 MHz. Comments are being sought on all aspects related to the licensing of this spectrum.

Changes to the 2500 MHz deadline for applications

Industry Canada has made changes to the Table of Key Dates related to the Licensing Framework for Broadband Radio Service (BRS) — 2500 MHz Band in order to align the application dates for both the 2500 MHz and the proposed AWS-3 auction processes.

Submitting comments

To ensure consideration, parties should submit their comments no later than September 4, 2014. Respondents are asked to provide their comments in electronic format (Microsoft Word or Adobe PDF) to the following email address: spectrum.auctions@ic.gc.ca. Soon after the close of the comment period, all comments will be posted on Industry Canada's Spectrum Management and Telecommunications Web site at www.ic.gc.ca/spectrum. All comments will be reviewed and considered by Industry Canada in order to arrive at its decisions regarding the above-mentioned proposals.

The Department will also provide interested parties with the opportunity to reply to comments from other parties. Reply comments will be accepted until October 2, 2014.

Written submissions should be addressed to the Senior Director, Spectrum Licensing and Auction Operations, Industry Canada, 235 Queen Street, Ottawa, Ontario K1A 0H5.

All submissions should cite the Canada Gazette, Part I, the publication date, the title and the notice reference number (SLPB-004-14).

Obtaining copies

Copies of this notice and of documents referred to herein are available electronically on Industry Canada's Spectrum Management and Telecommunications Web site at www.ic.gc.ca/spectrum.

Official versions of Canada Gazette notices can be viewed at www.gazette.gc.ca/rp-pr/p1/index-eng.html.

July 28, 2014

FIONA GILFILLAN
Director General
Spectrum Licensing Policy Branch

[31-1-o]

DEPARTMENT OF INDUSTRY

RADIOCOMMUNICATION ACT

Notice No. SMSE-010-14 — Release of SRSP-517, Issue 1

Notice is hereby given by Industry Canada that the following document comes into force immediately:

• Standard Radio System Plan SRSP-517, Issue 1: Technical Requirements for Broadband Radio Service (BRS) in the Band 2500-2690 MHz, which sets out the minimum technical requirements for the efficient utilization of this band.

The above document was published to reflect recent changes in Industry Canada's policy on BRS.

General information

This document has been coordinated with industry through the Radio Advisory Board of Canada (RABC).

Submitting comments

Interested parties are requested to provide their comments within 120 days of the date of publication of this notice in electronic format (Microsoft Word or Adobe PDF) to the Manager, Mobile Spectrum Planning (srsp.pnrh@ic.gc.ca).

Written submissions should be addressed to the Director General, Engineering, Planning and Standards Branch, Industry Canada, 235 Queen Street, Ottawa, Ontario K1A 0H5.

All submissions received by the close of the comment period will be posted on Industry Canada's Spectrum Management and Telecommunications Web site at www.ic.gc.ca/spectrum.

Obtaining copies

Copies of this notice and of documents referred to herein are available electronically on Industry Canada's Spectrum Manage-ment and Telecommunications Web site at www.ic.gc.ca/spectrum.

Official versions of Canada Gazette notices can be viewed at www.gazette.gc.ca/rp-pr/p1/index-eng.html.

July 8, 2014

DANIEL DUGUAY
Acting Director General
Engineering, Planning and Standards Branch

[31-1-o]

NOTICE OF VACANCY

NATIONAL FILM BOARD

Government Film Commissioner and Chairperson (full-time position)

Salary range: From $194,500 to $228,800
Location: Montréal, Quebec

The National Film Board (NFB) is a cultural agency, governed by the National Film Act. As a national film institution and member of the Canadian Heritage portfolio, the NFB is responsible for initiating and promoting the production and distribution of films and other audiovisual works intended for Canadian audiences and foreign markets, in order to increase viewers' knowledge and understanding of the social and cultural realities of Canada. The NFB is accountable for its activities to Parliament through the Minister of Canadian Heritage and Official Languages.

The NFB is recognized as one of the world's great creative laboratories. As Canada's public producer and distributor, it produces and distributes distinctive, relevant and innovative audiovisual productions.

Its works offer special insight into the diversity and vitality of our culture and are an essential part of our national cultural heritage. The NFB works in collaboration with emerging and established filmmakers, creators and co-producers in every region of Canada, with Aboriginal and culturally diverse communities, as well as with partners around the world. Its international successes have garnered Canadian filmmaking unrivalled attention worldwide, affirming the excellence of the NFB's offerings. Since its founding in 1939, the NFB has created over 13 000 productions and won over 5 000 awards, including 8 Webbys, 12 Oscars and more than 90 Genies. Its creators continue to break new ground in both the form and content of documentaries, animated films and multiplatform digital projects, as well as in digital and 3D animation.

As Chief Executive Officer of the NFB, the Government Film Commissioner and Chairperson provides leadership and guidance to the organization in the formulation of its strategic direction and ensures the institution carries out its mandate and objectives effectively.

The ideal candidate would have a degree from a recognized university in a relevant field of study or a combination of equivalent education, job-related training and/or experience. The candidate should have experience leading and developing complex organizations and high performance teams, as well as managing financial resources. Experience promoting an organization at the national level while working with a board of directors to develop strategies, plans and objectives is sought. Chief executive officer or senior executive experience, ideally in the cultural sector, such as the film, television, video and new media industries, is desired. The candidate should have experience building and maintaining productive and multipartite relationships with partner organizations and diverse stakeholders. Moreover, the candidate should have experience working within a dynamic and competitive business environment, with a record of developing innovative industry partnerships.

The ideal candidate would have knowledge and understanding of sound business management practices and principles, including within the fields of human resources and financial management, and good corporate governance skills. Knowledge of the mandate of the National Film Board and its main activities, productions, history and place in the Canadian and international film communities is desired. The candidate should have knowledge of the audiovisual industry as well as of the federal government's priorities in order to set the strategic goals of the NFB in the context of its mission as set out in the National Film Act and other governing legislation. Additionally, the candidate would have knowledge of the Canadian government and public policy.

The ideal candidate would have the ability to lead an organization and inspire high performance from board members and staff, and convert the vision into a strategic action plan. The ability to promote the NFB at the national level and develop effective working relationships with the NFB's partners, the Government and stakeholders in carrying out its mandate, while identifying and pursuing innovative initiatives for leveraging funding through the development and implementation of new business opportunities and partnerships, is sought. Moreover, the candidate should possess discretion and superior communication skills, both oral and written, and the ability to manage communications with a variety of stakeholders and the media, while also promoting and sustaining a positive work climate based on excellence, innovation, creativity and teamwork.

The ideal candidate would adhere to high ethical standards and possess superior interpersonal skills, integrity, sound judgment, tact and diplomacy.

Proficiency in both official languages would be preferred.

The selected candidate must not have any pecuniary interest, direct or indirect, individually or as a shareholder or partner or otherwise, in commercial film activity.

The successful candidate must reside in or be willing to relocate to the Montréal region or to a location within reasonable commuting distance, and be prepared to travel occasionally.

The Government is committed to ensuring that its appointments are representative of Canada's regions and official languages, as well as of women, Aboriginal peoples, disabled persons and visible minorities.

The selected candidate must comply with the Ethical and Political Activity Guidelines for Public Office Holders. The Guidelines are available on the Governor in Council Appointments Web site, under “Reference Material,” at www.appointments-nominations.gc.ca/index.asp?lang=eng.

The selected candidate will be subject to the Conflict of Interest Act. Public office holders appointed on a full-time basis must submit to the Office of the Conflict of Interest and Ethics Commissioner, within 60 days of appointment, a confidential report in which they disclose all of their assets, liabilities and outside activities. For more information, please visit the Office of the Conflict of Interest and Ethics Commissioner's Web site at http://ciec-ccie.gc.ca/Default.aspx?pid=1&lang=en.

This notice has been placed in the Canada Gazette to assist the Governor in Council in identifying qualified candidates for this position. It is not, however, intended to be the sole means of recruitment.

Further details about the organization and its activities can be found on its Web site at www.nfb.ca.

For more information, please contact Michelle Richard at 613-742-3208 or Leslie Feldman at 613-742-3212, or either of them by email at lfeldman@boyden.com. To apply for this position, please visit the Boyden Web site at www.boyden.ca.

English and French notices of vacancies will be produced in an alternative format upon request. For further information, please contact GICA-NGEC@pco-bcp.gc.ca.

[31-1-o]

NOTICE OF VACANCY

SOCIAL SCIENCES AND HUMANITIES RESEARCH COUNCIL

President (full-time position)

Salary range: From $223,800 to $263,200
Location: Ottawa, Ontario

The Social Sciences and Humanities Research Council (SSHRC) is a federal research granting agency established by an Act of Parliament in 1977. The President of SSHRC is accountable for the implementation and administration of the federal Social Sciences and Humanities Research Council Act. This Act mandates SSHRC to promote and assist research and scholarship in the social sciences and humanities, and to advise the Minister of Industry on such matters relating to research that the Minister may refer to SSHRC for its consideration.

By investing in the development and promotion of the best Canadian research, SSHRC builds knowledge about people, past and present, with a view toward creating a better future. By investing in research grants, scholarships, fellowships and research training, SSHRC develops new and talented leaders; enables the highest levels of research excellence in Canada; and facilitates knowledge sharing and collaboration across research disciplines, postsecondary institutions and all sectors of society.

The President reports to Parliament through the Minister of Industry. SSHRC is a member of the Industry Portfolio. SSHRC's President is supported by a governing council appointed by the Governor in Council. The governing council works with the President to ensure that SSHRC's priorities and programs support the highest quality of research, training and knowledge mobilization, and to enable a strong, vibrant research community in the social sciences and humanities, to the benefit of Canada and the world.

The ideal candidate would possess a doctoral degree from a recognized university in a relevant field of study or an acceptable combination of equivalent education, job-related training and/or experience.

The ideal candidate would have significant experience in research management within academia, the private and/or public sector as well as possess executive management experience, ideally within a large complex organization, in the development and implementation of strategic initiatives and the management of financial and human resources. Experience dealing with senior representatives of academia, the private sector and government, including building and maintaining collaborative partnerships, is desired. Related professional experience gained within a university in Canada would be considered an asset.

The ideal candidate would be knowledgeable about SSHRC's mandate, role and responsibilities, as well as its legislative framework, including the Social Sciences and Humanities Research Council Act and the Financial Administration Act. Knowledge of the Government of Canada's structure and operations, and its relationship with SSHRC, is desirable as is the knowledge of the principles of sound management and corporate governance, as well as risk management principles and practices. The ideal candidate would be knowledgeable about Canada's academic community, including challenges and opportunities related to generating knowledge, to developing talented leaders, and to facilitating knowledge sharing and collaboration across research disciplines, post-secondary institutions and all sectors of society. Knowledge of the current challenges and opportunities related to social sciences and humanities research in understanding, for example, social, cultural, technological, environmental and economic issues is desired. He or she would also be familiar with key SSHRC partners and leaders, as well as emerging and global trends.

The ideal candidate would have the ability to provide the corporate vision and leadership needed to pursue SSHRC's mandate, realize its strategic direction, and identify, analyze, and define longrange priorities and strategies, as well as the ability to mobilize SSHRC staff, stakeholders and partners to work toward a shared vision and common goals. The ideal candidate would also have the ability to integrate varied and complex requirements and expectations originating from external stakeholders, partners, and the Government of Canada. He or she would be able to develop effective working relationships with the Minister and his office, the Minister of State and his office, the Deputy Minister and SSHRC's partners and stakeholders. Excellent communication skills, both written and oral, are also required.

To achieve SSHRC's objectives and carry out its mandate, the President would be a strategic and innovative leader who possesses sound judgment, impartiality and is a person of high integrity. He or she would possess superior interpersonal skills, and holds stature and credibility in the social sciences and humanities community.

Proficiency in both official languages would be preferred.

The Social Sciences and Humanities Research Council (SSHRC) is located in Ottawa; therefore, the successful candidate must reside in, or be willing to relocate to, the National Capital Region or to a location within reasonable commuting distance. The successful candidate must also be willing to travel extensively within Canada and internationally, as required.

The Government is committed to ensuring that its appointments are representative of Canada's regions and official languages, as well as of women, Aboriginal peoples, disabled persons and visible minorities.

The selected candidate must comply with the Ethical and Political Activity Guidelines for Public Office Holders. The Guidelines are available on the Governor in Council Appointments Web site, under “Reference Material,” at www.appointments-nominations.gc.ca/index.asp?lang=eng.

The selected candidate will be subject to the Conflict of Interest Act. Public office holders appointed on a full-time basis must submit to the Office of the Conflict of Interest and Ethics Commissioner, within 60 days of appointment, a confidential report in which they disclose all of their assets, liabilities and outside activities. For more information, please visit the Office of the Conflict of Interest and Ethics Commissioner's Web site at http://ciec-ccie.gc.ca/Default.aspx?pid=1&lang=en.

This notice has been placed in the Canada Gazette to assist the Governor in Council in identifying qualified candidates for this position. It is not, however, intended to be the sole means of recruitment.

Further details about SSHRC and its activities can be found on its Web site at www.sshrc-crsh.gc.ca.

For more information, please contact Michelle Richard at 613-742-3208 or Richard Rankin at 613-742-3207, or either of them by email at rrankin@boyden.com. To apply for this position, please visit the Boyden Web site at www.boyden.ca.

English and French notices of vacancies will be produced in an alternative format upon request. For further information, please contact GICA-NGEC@pco-bcp.gc.ca.

[31-1-o]